CCL2 enhances pluripotency of human induced pluripotent stem cells by activating hypoxia related genes

Yuki Hasegawa, Dave Tang, Naoko Takahashi, Yoshihide Hayashizaki, Alistair R R Forrest, Harukazu Suzuki,

Research output: Contribution to journal/periodicalArticleScientificpeer-review

Abstract

Standard culture of human induced pluripotent stem cells (hiPSCs) requires basic Fibroblast Growth Factor (bFGF) to maintain the pluripotent state, whereas hiPSC more closely resemble epiblast stem cells than true naïve state ES which requires LIF to maintain pluripotency. Here we show that chemokine (C-C motif) ligand 2 (CCL2) enhances the expression of pluripotent marker genes through the phosphorylation of the signal transducer and activator of transcription 3 (STAT3) protein. Moreover, comparison of transcriptomes between hiPSCs cultured with CCL2 versus with bFGF, we found that CCL2 activates hypoxia related genes, suggesting that CCL2 enhanced pluripotency by inducing a hypoxic-like response. Further, we show that hiPSCs cultured with CCL2 can differentiate at a higher efficiency than culturing with just bFGF and we show CCL2 can be used in feeder-free conditions in the absence of LIF. Taken together, our finding indicates the novel functions of CCL2 in enhancing its pluripotency in hiPSCs.

Original languageEnglish
Pages (from-to)5228
JournalScientific Reports
Volume4
DOIs
Publication statusPublished - 2014

Fingerprint

Dive into the research topics of 'CCL2 enhances pluripotency of human induced pluripotent stem cells by activating hypoxia related genes'. Together they form a unique fingerprint.

Cite this